Article Details
Retrieved on: 2020-12-31 11:13:22
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Vanguard Group Inc. now owns 203,888,386 shares of the biopharmaceutical company's stock valued at $11,988,638,000 after acquiring an additional ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here